AI therapy aims to curb suicide risk in older HIV patients
NCT ID NCT07339189
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an AI-powered therapy program can help older adults (50+) living with HIV who are at risk for suicide. Participants watch short videos teaching coping skills and can chat with a coach. The goal is to see if this approach is practical and helps people manage difficult emotions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-delivered dialectical behavioral therapy (AI-DBT)
What this could lead to
If successful, this could provide a new, accessible way to help older adults with HIV manage suicidal thoughts and emotions.
What could go wrong
This is a small, early pilot study with only 50 participants, so results may not apply to everyone. The AI therapy is new and may not work as well as in-person sessions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Jersey Community Research Initiative
RECRUITINGNewark, New Jersey, 07103, United States
-
RWJB Infectious Disease
NOT_YET_RECRUITINGNewark, New Jersey, 07112, United States
Contact Email: •••••@•••••